Nuvasive INC
SEC CIK 1142596 · NUVA · last insider filing 2023-09-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Friel Robert F | Director | filed 2016 - 2023 |
| Capps Vickie L | Director | filed 2015 - 2023 |
| Huennekens R Scott | Director | filed 2018 - 2023 |
| Deford John A | Director | filed 2018 - 2023 |
| Norwalk Leslie V | Director | filed 2014 - 2023 |
| Kadia Siddhartha | Director | filed 2021 - 2023 |
| Wolterman Dan | Director | filed 2015 - 2023 |
| Barry James Christopher | Director · Chief Executive Officer | filed 2018 - 2023 |
| Raimundo Amy Belt | Director | filed 2021 - 2023 |
| Rosenberg Donald J | Director | filed 2016 - 2022 |
| Lucier Gregory T | Director · Chairman & CEO | filed 2013 - 2021 |
| Ohalleran Michael D | Director | filed 2016 - 2019 |
| Leddy Peter Michael | Director · EVP, People and Culture | filed 2011 - 2019 |
| Farrell Peter C | Director | filed 2006 - 2018 |
| Howe Lesley H | Director | filed 2006 - 2018 |
| Miles Patrick | Director · Senior VP, Marketing | filed 2006 - 2017 |
| Blair Jack R | Director | filed 2006 - 2016 |
| Lukianov Alexis V | Director · Chief Exec. Officer & Chairman | filed 2006 - 2015 |
| More Eileen M | Director | filed 2007 - 2014 |
| Hunt Robert J | Director | filed 2006 - 2014 |
| Treharne Richard III | Director | filed 2009 - 2013 |
| Yuan Hansen A | Director | filed 2006 - 2009 |
| Blair James C | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sisitsky Nathaniel | SVP & General Counsel | filed 2018 - 2023 |
| Harbaugh Matthew K | EVP and CFO | filed 2020 - 2023 |
| Wolf Dale A. | SVP, Global Operations | filed 2020 - 2023 |
| Farrington Michael | SVP, People and Culture | filed 2022 - 2023 |
| Rosenbaum Marc Wade | Chief Accounting Officer | filed 2022 - 2023 |
| Morton Andrew C. | SVP, CHRO | filed 2022 - 2022 |
| Calafiore Massimo | EVP, Global Business Units | filed 2020 - 2022 |
| Vitale Lucas | Chief Human Resources Officer | filed 2019 - 2021 |
| Boucher Brent J. | EVP, Global Commercial | filed 2020 - 2021 |
| Link Matthew | President, U.S. Sales and Svc. | filed 2013 - 2020 |
| Mcclintock Paul | President, U.S. Commercial | filed 2019 - 2019 |
| Asarpota Rajesh | CFO | filed 2017 - 2019 |
| Stafslien Joan | EVP and General Counsel | filed 2016 - 2019 |
| Carol Cox | EVP, Corporate Affairs and HR | filed 2014 - 2019 |
| Rozow Stephen | EVP, Global Process | filed 2017 - 2018 |
| Sylvain Jereme M | Chief Accounting Officer | filed 2016 - 2018 |
| Kiil Harry Skip | EVP International | filed 2017 - 2017 |
| Hannon Jason | VP, Legal Affairs & Secretary | filed 2006 - 2017 |
| Blackford Quentin S. | CFO and CAO | filed 2014 - 2017 |
| Roschak Edmund J | CEO, NuVasive Spec. Orthopedic | filed 2016 - 2017 |
| Hanson Jason David | EVP, Strategy, Corp Dev & GC | filed 2015 - 2015 |
| Powers Russell | Exec. VP Sales Int'l Ops | filed 2013 - 2015 |
| Valentine Keith | President and COO | filed 2006 - 2015 |
| Lambert Michael | Executive Vice Pres. & CFO | filed 2009 - 2014 |
| Paolucci Michael E | Exec. V.P., Global HR | filed 2014 - 2014 |
| Hunsaker Craig E | SVP, Global Human Resources | filed 2011 - 2014 |
| Rydin Jeffrey P | Senior V.P., U.S. Sales | filed 2007 - 2012 |
| Lipschultz Tyler | Exec. VP., Global Operations | filed 2011 - 2012 |
| Oboyle Kevin C | CFO and Executive VP | filed 2006 - 2009 |
| Spangler Jonathan | VP & Chief Patent Counsel | filed 2006 - 2006 |
| Cornwall G Bryan | VP, Research & Development | filed 2006 - 2006 |
| Skinner James J | VP,Strategic Sales Development | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.